Enlarge this image Newer blood tests can help doctors diagnose Alzheimer’s disease without a brain scan or spinal tap. But some tests…
-
-
Enlarge this image The image shows amyloid plaques in the brains of three patients in the early stages of Alzheimer’s. Those plaques…
-
Enlarge this image The Food and Drug Administration has fully approved Leqembi, the first drug shown to slow down Alzheimer’s disease. Andrew…
-
Enlarge this image In patients with Alzheimer’s disease, a substance called beta-amyloid can form toxic clumps in between neurons. Drugs like lecanemab…
-
Enlarge this image U.S. health officials approved Leqembi, a new Alzheimer’s drug that modestly slows the brain disease. The FDA granted accelerated…
-
Enlarge this image This illustration made available by the National Institute on Aging/National Institutes of Health depicts cells in an Alzheimer’s-affected brain.…
